Logo image of EKOP.BR

EKOPAK NV (EKOP.BR) Stock Fundamental Analysis

EBR:EKOP - Euronext Brussels - BE0974380124 - Common Stock - Currency: EUR

6.3  -0.12 (-1.87%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to EKOP. EKOP was compared to 44 industry peers in the Commercial Services & Supplies industry. EKOP has a bad profitability rating. Also its financial health evaluation is rather negative. EKOP is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EKOP had negative earnings in the past year.
EKOP had a negative operating cash flow in the past year.
In the past 5 years EKOP always reported negative net income.
EKOP had negative operating cash flow in 4 of the past 5 years.
EKOP.BR Yearly Net Income VS EBIT VS OCF VS FCFEKOP.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

EKOP's Return On Assets of -7.84% is on the low side compared to the rest of the industry. EKOP is outperformed by 72.73% of its industry peers.
EKOP has a worse Return On Equity (-29.69%) than 75.00% of its industry peers.
Industry RankSector Rank
ROA -7.84%
ROE -29.69%
ROIC N/A
ROA(3y)-4.22%
ROA(5y)-2.9%
ROE(3y)-12.98%
ROE(5y)-8.4%
ROIC(3y)N/A
ROIC(5y)N/A
EKOP.BR Yearly ROA, ROE, ROICEKOP.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200 250

1.3 Margins

EKOP has a Gross Margin of 30.21%. This is in the lower half of the industry: EKOP underperforms 65.91% of its industry peers.
EKOP's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for EKOP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.64%
GM growth 5Y-5.79%
EKOP.BR Yearly Profit, Operating, Gross MarginsEKOP.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

0

2. Health

2.1 Basic Checks

EKOP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EKOP remains at a similar level compared to 1 year ago.
Compared to 5 years ago, EKOP has more shares outstanding
Compared to 1 year ago, EKOP has a worse debt to assets ratio.
EKOP.BR Yearly Shares OutstandingEKOP.BR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M
EKOP.BR Yearly Total Debt VS Total AssetsEKOP.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

EKOP has an Altman-Z score of 0.35. This is a bad value and indicates that EKOP is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of EKOP (0.35) is worse than 72.73% of its industry peers.
A Debt/Equity ratio of 1.30 is on the high side and indicates that EKOP has dependencies on debt financing.
EKOP has a Debt to Equity ratio of 1.30. This is in the lower half of the industry: EKOP underperforms 65.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.3
Debt/FCF N/A
Altman-Z 0.35
ROIC/WACCN/A
WACC6.23%
EKOP.BR Yearly LT Debt VS Equity VS FCFEKOP.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

EKOP has a Current Ratio of 0.80. This is a bad value and indicates that EKOP is not financially healthy enough and could expect problems in meeting its short term obligations.
EKOP's Current ratio of 0.80 is on the low side compared to the rest of the industry. EKOP is outperformed by 79.55% of its industry peers.
A Quick Ratio of 0.64 indicates that EKOP may have some problems paying its short term obligations.
The Quick ratio of EKOP (0.64) is worse than 79.55% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.64
EKOP.BR Yearly Current Assets VS Current LiabilitesEKOP.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

7

3. Growth

3.1 Past

EKOP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -288.77%.
EKOP shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.20%.
EKOP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.09% yearly.
EPS 1Y (TTM)-288.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-249.72%
Revenue 1Y (TTM)32.2%
Revenue growth 3Y61.78%
Revenue growth 5Y36.09%
Sales Q2Q%-30.87%

3.2 Future

The Earnings Per Share is expected to grow by 60.98% on average over the next years. This is a very strong growth
EKOP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.77% yearly.
EPS Next Y56.46%
EPS Next 2Y44.28%
EPS Next 3Y25.99%
EPS Next 5Y60.98%
Revenue Next Year35.82%
Revenue Next 2Y27.15%
Revenue Next 3Y16.96%
Revenue Next 5Y25.77%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
EKOP.BR Yearly Revenue VS EstimatesEKOP.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
EKOP.BR Yearly EPS VS EstimatesEKOP.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2028 0 0.5 1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

EKOP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EKOP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EKOP.BR Price Earnings VS Forward Price EarningsEKOP.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EKOP.BR Per share dataEKOP.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

EKOP's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.28%
EPS Next 3Y25.99%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EKOP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EKOPAK NV

EBR:EKOP (6/23/2025, 2:44:43 PM)

6.3

-0.12 (-1.87%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)04-11 2025-04-11/amc
Earnings (Next)N/A N/A
Inst Owners0.73%
Inst Owner ChangeN/A
Ins Owners82.57%
Ins Owner ChangeN/A
Market Cap110.25M
Analysts77.78
Price Target5.46 (-13.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-70.28%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-328.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.31
P/FCF N/A
P/OCF N/A
P/B 2.68
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-1.78
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS2.72
BVpS2.35
TBVpS-0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.84%
ROE -29.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.21%
FCFM N/A
ROA(3y)-4.22%
ROA(5y)-2.9%
ROE(3y)-12.98%
ROE(5y)-8.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.64%
GM growth 5Y-5.79%
F-Score2
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 1.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 351.32%
Cap/Sales 57.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.64
Altman-Z 0.35
F-Score2
WACC6.23%
ROIC/WACCN/A
Cap/Depr(3y)366.86%
Cap/Depr(5y)479.35%
Cap/Sales(3y)50.41%
Cap/Sales(5y)51.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-288.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-249.72%
EPS Next Y56.46%
EPS Next 2Y44.28%
EPS Next 3Y25.99%
EPS Next 5Y60.98%
Revenue 1Y (TTM)32.2%
Revenue growth 3Y61.78%
Revenue growth 5Y36.09%
Sales Q2Q%-30.87%
Revenue Next Year35.82%
Revenue Next 2Y27.15%
Revenue Next 3Y16.96%
Revenue Next 5Y25.77%
EBIT growth 1Y-284%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1036.36%
EBIT Next 3Y182.37%
EBIT Next 5Y141.55%
FCF growth 1Y-159.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-474.52%
OCF growth 3YN/A
OCF growth 5YN/A